
|Articles|December 27, 2021
FDA approves HIV pre-exposure preventive injection
Author(s)Keith A. Reynolds
Apretude is approved for use in at-risk adults and adolescents to reduce the risk of sexually acquired HIV.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Top 5 women's health headlines you missed in October 2025
2
Postpartum complications common in first year after birth
3
FDA approves fosfomycin for treating cUTIs
4
Elective egg freezing on the rise, but few patients return to use preserved oocytes
5
















